Photoclinic: Cutaneous Calcinosis in a Child With Tertiary Hyperparathyroidism

Consultant for PediatriciansConsultant for Pediatricians Vol 4 No 10
Volume 4
Issue 10

Photoclinic: Cutaneous Calcinosis in a Child With Tertiary Hyperparathyroidism

An 11-year-old boy who was receiving continuous ambulatory peritoneal dialysis becauseof end-stage renal disease secondary to membranoproliferative glomerulonephritiswas hospitalized with hypocalcemia 2 days after subtotal parathyroidectomy.Before the surgery, multiple lesions were noted on the child's thighs (shown here),upper arms, and abdomen.The lesions, some with calciumdeposits, were hard and painful.A biopsy of the lesions revealed histologicfindings consistent with cutaneouscalcinosis.

Surgery was performed becauseof tertiary hyperparathyroidism--parathyroid hormone (PTH) level of1552 pg/mL--and persistent hypercalcemia(calcium corrected for albuminlevel of 11.9 mg/dL). The preoperativeserum phosphorus level was7.5 mg/dL.

Postoperative laboratory valuesincluded an ionized calcium level of3.45 mg/dL; total calcium, 6.6 mg/dL;albumin, 2.6 g/dL (corrected calcium,7.72 mg/dL); phosphorus,2.6 mg/dL; and PTH, 19 pg/mL.

Nerissa C. Kreher, MD, andEmily Walvoord, MD, of Indianapoliswrite that soft tissue calcificationis a known complication of end-stagerenal disease. High levels of calciumx phosphate product lead to the formationof hydroxyapatite crystalsthat are deposited in the skin and other tissues. Parathyroidectomy decreases PTH levels,thereby decreasing the calcium x phosphate product.

Hypocalcemia after parathyroidectomy is caused by the rapid uptake of calcium by the skeleton,referred to as "hungry bone syndrome." End-stage renal disease initially leads to secondaryhyperparathyroidism because of a combination of hyperphosphatemia and mild hypocalcemia.Tertiary hyperparathyroidism occurs when the parathyroid glands become autonomous as a resultof uncontrolled secondary hyperparathyroidism.

Cutaneous calcinosis often resolves with parathyroidectomy. This child was dischargedafter 5 days, and supplemental calcium (calcium carbonate, 13,500 mg/d) and calcitriol (3 µg/d)were initiated. Three weeks later, the calcifications had diminished and the calcium and PTHlevels had increased.

Related Videos
Wendy Ripple, MD
Wendy Ripple, MD
Lawrence Eichenfield, MD
Lawrence Eichenfield, MD | Image credit: KOL provided
FDA approves B-VEC to treat dystrophic epidermolysis bullosa patients 6 months and older | Image Credit: bankrx - Image Credit: bankrx -
Related Content
© 2024 MJH Life Sciences

All rights reserved.